CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $478.64 | $479K | 3,130 |
| 2025-12-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $480.14 | $240K | 2,630 |
| 2025-12-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −769 | $481.72 | $370K | 1,861 |
| 2025-12-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,731 | $482.95 | $836K | 130 |
| 2025-12-02 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 50,000 | ||
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,978 | $477.94 | $945K | 12,647 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,935 | $478.98 | $1.4M | 9,712 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −4,545 | $479.79 | $2.2M | 5,167 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,904 | $480.80 | $1.4M | 2,263 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,691 | $481.63 | $814K | 572 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −338 | $482.69 | $163K | 234 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −234 | $483.42 | $113K | 0 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,065 | $477.94 | $509K | 6,810 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,581 | $478.98 | $757K | 5,229 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,447 | $479.79 | $1.2M | 2,782 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,563 | $480.80 | $751K | 3,867 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −911 | $481.63 | $439K | 2,956 |
| 2025-12-01 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −182 | $482.69 | $88K | 2,774 |
Page 175 of 214 · 4,273 trades